Delivery Order SPE2DE21D7020-SPE2D625F2UQF
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a delivery order valued at $21,828.61 for Agent Drug Coated Balloon devices under a fixed price contract with economic price adjustment provisions. The contract was awarded on July 22, 2025, by the Defense Health Agency's Medical Supply Chain and is scheduled for completion by July 29, 2025. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular medical devices to federal healthcare agencies. The award is not...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- Boston Scientific Corp has been awarded a delivery order valued at $9,001.72 for agent drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on September 4, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract is funded by the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. Drug-coated balloons are specialized...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2UQFDelivery Order
Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and aligns with Boston Scientific's established role as a primary supplier of advanced cardiovascular intervention technologies to federal healthcare agencies. This delivery order falls within Boston Scientific's broader portfolio of federal medical device contracts with the Defense Health Agency and other federal healthcare systems. As a leading medical technology company, Boston Scientific supplies specialized cardiovascular devices including stents, catheters, and drug-coated balloons to support clinical operations across federal healthcare networks. The relatively compressed performance timeline reflects the urgent medical supply needs typical of federal healthcare operations, with the delivery order fulfilling immediate procurement requirements for this critical cardiovascular intervention technology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.2k | 9/8/25 |